-

Konovo Launches Survey Studio, Accelerating Survey Design to Programming from Weeks to Minutes

Deploying an intelligent platform with AI agents to automate and orchestrate across workflows, reduce compliance risk, and maximize expert bandwidth

WATERTOWN, Mass.--(BUSINESS WIRE)--Konovo, a technology-first healthcare intelligence company, today announced Survey Studio, a new product that helps organizations design and script therapeutic-specific healthcare surveys in minutes—not weeks. Built on Konovo’s trusted life sciences intelligence and powered by agentic AI, Survey Studio streamlines the research design and programming workflow with precision, freeing teams to focus on data interpretation and strategic insights.

"With Survey Studio, healthcare researchers have an AI tool trained on healthcare intelligence, to help them build a field-ready survey in real-time - and use it to deliver measurable business impact." Tal Rosenberg, CEO, Konovo

Share

“The Life Science industry is moving faster and changing quicker than ever, but this cannot come at the cost of quality or compliance,” said Tal Rosenberg, CEO of Konovo. “We developed Survey Studio to give healthcare researchers an AI tool trained on healthcare intelligence, which can understand their context, governance requirements, and research needs, and help them build a field-ready survey in real time. It is a clear example of how AI and healthcare intelligence can deliver measurable business impact.”

Survey Studio is powered by the core of Konovo’s intelligent platform, a base of continuously updated and verified life sciences intelligence combined with 15+ years of healthcare market research expertise. AI “agents” act with governance and guardrails to apply survey rules and context instantly, bringing together questionnaire design and survey programming into one workflow and ensuring accuracy, consistency, and compliance by design.

Through an exclusive healthcare and life sciences partnership with Metaforms, Survey Studio integrates Metaforms’ programming AI technology to move users from draft to fully programmed, field-ready surveys in minutes. This collaboration ensures speed with expert oversight, creating repeatable survey quality across studies and use cases—from ATU and brand tracking to patient journey, opportunity assessment, segmentation, and more

“Integrating our programming AI with Konovo’s Survey Studio gives users a seamless solution that accelerates workflows while keeping experts in control,” said Akshat Tyagi, Founder & CEO of Metaforms. “It’s not just about speed—it’s about empowering teams to focus on insights that drive organizational value.”

Survey Studio seamlessly automates the most time-consuming aspects of survey design and programming while assuring the highest quality. It applies:

  • Codified healthcare research expertise: Modelled on 15+ years of proprietary healthcare research data, proven design standards, and pre-validated methodology
  • Industry-validated information: Survey context and logic grounded in regulatory and scientific data sources (FDA, SEC, ClinicalTrials.gov, PubMed)
  • Human-in-the-loop rigor: AI tools instantly apply and carry forward survey rules, logic, and validated context, with final human-in-the-loop approval
  • Privacy and compliance, built in: Your data stays private and secure—never shared or used to train our AI. Every survey includes built-in HIPAA, GDPR, and compliance safeguards.

Konovo is among the first to apply agentic AI to healthcare market research—combining automation, data integrity, and human insight to redefine how surveys are created.

Survey Studio will be available in Q4 2025 from Konovo.

For more information, visit www.konovo.com.

About Konovo

Konovo is a global healthcare company on a mission to transform research through technology. Konovo simplifies the research process, connects fragmented insights, and enhances access to hard-to-reach healthcare professionals.

Konovo supports leading market research agencies, consultancies, and pharmaceutical and healthcare brands, by connecting them to specialized healthcare audiences— physicians, KOLs, patients, caregivers, payers, and allied healthcare professionals—via an intelligent platform.

Konovo builds on a long history of success in research through the merger of InCrowd, Survey Healthcare Global (SHG), and GlocalMind that was formerly known as Apollo Intelligence. Operating across the Americas, Europe, and Asia, Konovo connects the industry to an extensive network of audiences, partners, and data, enabling deeper, more actionable insights across healthcare.

Konovo is a portfolio company of Frazier Healthcare Partners. To learn more, visit www.konovo.com.

Contacts

Mary Kae Marinac, PR Representative for Konovo
mk@mkmarinac.com
978-685-3136

Konovo


Release Summary
Konovo debuted Survey Studio, a solution using agentic AI to help organizations design therapeutic-specific healthcare surveys in minutes, not weeks.
Release Versions

Contacts

Mary Kae Marinac, PR Representative for Konovo
mk@mkmarinac.com
978-685-3136

Social Media Profiles
More News From Konovo

Technology Innovator Jeremy Brody Joins Konovo Advisory Board to Accelerate AI-Driven Transformation

WATERTOWN, Mass.--(BUSINESS WIRE)--Konovo, a technology-first healthcare intelligence company, today announced the appointment of healthcare technology pioneer Jeremy Brody as a board advisor. With a 30-year track record of innovation in market research and health data technologies, Brody will help Konovo to accelerate the expansion of its AI-native intelligent platform. Presently Managing Director of Brody Capital & Advisors (BC&A), Brody brings deep industry expertise to Konovo’s miss...

Konovo Names Tim Albury as Chief Financial Officer (CFO)

WATERTOWN, Mass.--(BUSINESS WIRE)--Konovo named healthcare data industry veteran Tim Albury as its Chief Financial Officer, helping the firm to transform life science market research....

Konovo Expands Board with Appointment of Gadi Lachman, Reinforcing Commitment to Insights Connectivity and Tech Innovation

WATERTOWN, Mass.--(BUSINESS WIRE)--Konovo appointed Gadi Lachman to its board of directors, a move that will help accelerate its work to transform life science market insights....
Back to Newsroom